drugset / Trial / NCT00736931
Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam
RandomizedCrossoverDouble-blindBasic science
Summary
The primary objective of the study is to evaluate the neurocognitive effects of brivaracetam
Timeline
- Start
- 2008-07
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brivaracetam | Small molecule | 10 mg | — |
| Comparator | Levetiracetam | Other / unclassified | 500 mg | — |
| Comparator | Lorazepam | Small molecule | 2 mg | — |